A comprehensive view of Cencora. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Cencora to host inaugural ThinkLive Cell and Gene Therapy Summit to foster collaboration and accelerate product commercialization in CGT sector; the virtual event will convene industry leaders, FDA representatives and patient advocacy groups
Published:
May 08, 2024
by Cencora
|
Cencora Inc. - Management Change/Compensation - Form 8-K
Published:
May 03, 2024
by U.S. Markets (Alternative Disclosure) via PUBT
|
CENCORA, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
May 01, 2024
by SEC Edgar Filings
|
CENCORA, INC. - (8-K) - Disclosing Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Published:
May 01, 2024
by SEC Edgar Filings
|
CENCORA, INC. - (8-K) - Disclosing Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits
Published:
April 23, 2024
by SEC Edgar Filings
|
Ask us about our Bioeconomy market view